Single User License, Team License, Corporate License
Published January 12, 2018
Regenerative medicine is a branch involved in the repair, replace and regenerate tissues and organs affected due to injury, disease or natural ageing process. These medicines can restore the functionality of cells and tissues and are used in various strategies like cell therapy, gene therapy, and tissue engineering. Many firms and industries are trying to develop and improve the technological approaches to increase the market.
Global Regenerative Medicines Market Segments size & growth:
The market is valued at USD 17.625 Billion in 2017 and is expected to reach USD 51.453 Billion by 2024 at a CAGR of 23.8%. The primary factors influencing the market growth are growing prevalence of chronic diseases such as bone and joint diseases and trauma emergencies, increasing the need for orthopaedic surgeries, innovation in stem cell therapy, technological innovations and tissue engineering.
Global Regenerative Medicines Market Segments share:
By application, the market is segmented into orthopaedic, oncology, diabetes, cardiology and central nervous system. Among this oncology is having the most significant share and fastest growth in the market. The market is majorly divided into products, application, therapy, material and agent type. By products, it is segmented into cell-based and acellular, and by therapy, the market is segmented into the cell, therapy, tissue and gene therapy. The application is segmented into orthopaedic, dermatology, cardiology, oncology and central nervous system. By material, the market is categorised into algae-derived alginate, synthetic polymer, polylactide- coglycolide, polyethylene glycol and hydrogels. Final segmentation is based on agent type it is into biologics, cell-based medical devices, and biopharmaceuticals. By geography, the market is predominant in Asia-Pacific, and it continues during the forecast period. North America is in its growing phase and is holding the largest in regenerative medicines market as the therapies are in the 3rd phase of clinical trials.
Global Regenerative Medicines Market Trends:
Global Regenerative Medicines Market Research Report Includes:
1.1. Executive Summary
1.2. Market Definition
1.3. The scope of the Study
2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. Analytics Tools & Model
2.4. Economic Indicators
2.4.1.Base Year, Base Currency & Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
3. Market Analysis
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of Substitutes
3.2.4 Threat of New Entrants
3.2.5 Industry Rivalry (Competitive Environment)
3.3. PESTLE Analysis
3.4. SWOT Analysis
3.4.5 Y-O-Y Analysis
4. Market Dynamics
4.1.1 Increase in corporate partnerships to accelerate development and commercialise of regenerative medicine.
4.1.2 Increase in global healthcare expenditure.
4.1.3 Rapid growth in ageing population.
4.1.4. Prevalence of chronic diseases and genetic disorders.
4.2.1 Cost of treatment.
4.2.2 Complex regeneration process.
4.2.3. Lack of guidelines.
4.2.4. Ethical concerns with the use of embryonic stem cell for research and development.
4.3.1. Strong product pipeline.
4.3.2. Great Demand for organ transplantation.
4.4.1 Stringent regulatory policies about stem cell technologies.
5. Global Regenerative Medicine Market – By Product
5.2 Cell-based products
5.2.1 Allogeneic products
5.2.2 Autologous products
5.3 Acellular products
6. Global Regenerative Medicine Market – By Application
6.2 Orthopaedic and musculoskeletal disorders
6.5 Central nervous system diseases
6.8 Bone graft substitutes
7. Global Regenerative Medicine Market – By Therapy
7.2 Cell therapy
7.4 Tissue therapy
7.5 Gene therapy
8. Global Regenerative Medicine Market – By Material
8.2 Algae-derived alginate
8.3 Synthetic polymer
8.5 Poly-ethylene glycol
9. Global Regenerative Medicine Market – by Agent type
9.2.1 Autologous fibroblasts
9.2.2 Hematopoietic stem and progenitor cells
9.3 Cell-based medical devices
9.3.1 Allogenic fibroblasts
9.3.2 Cell extraction
9.4.1 Tricalcium phosphate
9.4.2 Osteogenic protein
10. Global Regenerative Medicine Market – By Geography
10.1 North America
10.1.2 United States
10.2.5 United Kingdom
10.3.5 Australia & New Zealand
10.4 South America
10.5 The Middle East and Africa
10.5.2 Saudi Arabia
11. Global Regenerative Medicine Market – Company Profiles
11.1 Stryker Corporation
11.2 CONMED Corporation
11.3 Anika Therapeutics Inc.
11.4 Zimmer Holdings Inc.
11.5 Medtronic Inc.
11.6 Vericel corporation
11.7 Baxter International Inc.
11.9 DePuy Synthes Inc.
11.10 StemCells Inc.
11.11 rthrex Inc.
11.13 immer biomet holdings
11.15 mith & Nephew PLC
11.16 integra lifesciences corporation
12. Global Regenerative Medicine Market – Competitive Landscape
12.1 Market Share Analysis
12.2 Strategies Adopted by top companies
12.3 Merges, Acquisitions, Collaborations & Agreements
13. Market Insights
13.1 Industry Experts Insights
13.2 Analysts Opinions
13.3 Investment Opportunities
14.1 List of tables
14.2 List of figures